Episode: 51 - Bridging the Equity Gap in Oncology with Eugene Manley, Jr.
Are medical advancements closing or widening medical disparities? Eugene Manley, Jr., Ph.D., founder and CEO of the STEMM & Cancer Health Equity Foundation, breaks down why equity is still not completely measurable in clinical trials, what proper representation in studies is, and how certain demographics are at a disadvantage for biomarker tests compared to other groups with host Deborah Borfitz. Their conversation explores whether health equity in cancer trials is different compared to c...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The Scope of Things
Episode: 54 - Ken Getz and Rick Ward on Why Source Preparation Delays Clinical Trials
Episode: 53 - Daphne Smyth on the Chinese Drug Development Market Expansion
Episode: 52 - Raj Indupuri on Adoption Hurdles with AI Agents
Episode: 50 - Ramona Burress and Cassandra O’Neal on Health Equity That Works
Get summaries like this every morning.
Free AI-powered recaps of The Scope of Things and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.